Alzheimer’s treatment: study on STORZ MEDICAL’s Transcranial Pulse Stimulation (TPS) is among the top 10% most downloaded papers in Advanced Science


In December 2019, the first study1 on Transcranial Pulse Stimulation (TPS) with STORZ MEDICAL’s NEUROLITH® system was published in the prestigious journal Advanced Science. In the study, Beisteiner et al. evaluate the TPS method and present treatment results. The presented data shows that it is possible to improve brain performance with TPS and that there is a long-term effect.

Since its publication, the study has generated a lot of interest among experts, and there have been numerous articles in the media. This success is mirrored in Advanced Science’s download numbers. Among work published between January 2018 and December 2019, the study is among the top 10% most downloaded papers. In recognition of their scientific work, the authors have now received a »Certificate of Achievement« by Advanced Science.

About TPS
In 2018, Transcranial Pulse Stimulation (TPS) with the NEUROLITH® system was the first, and hitherto only, procedure of its kind to obtain market authorization for the »treatment of the central nervous system of patients with Alzheimer’s disease«. TPS was developed by STORZ MEDICAL in collaboration with a team of researchers from the Medical University of Vienna (Department of Neurology), led by Professor Roland Beisteiner, and Dr. Henning Lohse-Busch, Rheintalklinik, Bad Krozingen/Germany.

Further information on TPS and the new NEUROLITH® system is available on our website.

1) Beisteiner, R. et al.: Transcranial Pulse Stimulation with Ultrasound in Alzheimer’s Disease—A New Navigated Focal Brain Therapy, Adv. Sci. [online ahead of print], DOI: 10.1002/advs.201902583, 2019
Link to full paper: